Cargando…
Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
INTRODUCTION: Current approaches for treating sporadic Alzheimer's disease (sAD) focus on removal of amyloid beta 1‐42 (Aβ(1‐42)) or phosphorylated tau, but additional strategies are needed to reduce neuropathology at earlier stages prior to neuronal damage. Longstanding data show that calcium...
Autores principales: | Bathla, Shveta, Datta, Dibyadeep, Liang, Feng, Barthelemy, Nicolas, Wiseman, Robyn, Slusher, Barbara S, Asher, Jennifer, Zeiss, Caroline, Ekanayake‐Alper, Dil, Holden, Daniel, Terwilliger, Gordon, Duque, Alvaro, Arellano, Jon, van Dyck, Christopher, Bateman, Randall J., Xie, Zhongcong, Nairn, Angus C., Arnsten, Amy F. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617575/ https://www.ncbi.nlm.nih.gov/pubmed/37915375 http://dx.doi.org/10.1002/trc2.12431 |
Ejemplares similares
-
Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders
por: Yang, Shengtao, et al.
Publicado: (2022) -
Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII
por: Knedlík, Tomáš, et al.
Publicado: (2017) -
Glutamate Carboxypeptidase II in Aging Rat Prefrontal Cortex Impairs Working Memory Performance
por: Datta, Dibyadeep, et al.
Publicado: (2021) -
Deletion of glutamate carboxypeptidase II (GCPII), but not GCPIII, provided long‐term benefits in mice with traumatic brain injury
por: Ji, Tongjie, et al.
Publicado: (2023) -
The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex
por: Arnsten, Amy F. T., et al.
Publicado: (2020)